Are injections better than oral drugs in osteoporosis?

Hi,

Welcome to icliniq.com.

I read your query and can understand your concern.

Thank you for sharing your detailed medical history (attachment removed to protect patient’s identity). A T-score below 2.5 is diagnostic of osteoporosis and indicates the need for pharmacological treatment to reduce the risk of osteoporotic fractures.

Bisphosphonates such as Alendronate and Zoledronic acid are effective first-line therapies, provided there are no contraindications. However, they are known to cause gastrointestinal discomfort in some patients.

To help minimize these side effects, the following precautions are recommended:

1. Take the tablet in the morning on an empty stomach.
2. Swallow it with a full glass of water.
3. Remain upright for at least 30 to 45 minutes after taking the medication.
4. Avoid food and beverages for 30 to 45 minutes after ingestion.
5. Avoid wearing tight-fitting clothing.
6. Maintain adequate hydration.

If gastric discomfort persists despite these measures, switching to intravenous Zoledronic acid may be considered. Zoledronic acid eliminates gastrointestinal side effects as it is administered intravenously and requires only annual dosing. It is also a potent option for reducing fracture risk.

Denosumab is generally reserved for patients with specific indications, such as renal impairment, as discontinuation can be associated with rapid bone loss if not followed by appropriate therapy.

A “drug holiday” may be considered after three years of Alendronate therapy or five years of Zoledronic acid treatment, provided bone mineral density improves to above the osteoporotic range and bone turnover markers are satisfactory. Regular follow-up and appropriate investigations are essential to guide ongoing management.

I hope the information helps.

Kindly revert so I can assist you further.

Thank you.